1st Edition
Genetic Editing for Healthcare Advances in Disease Management
Foreword by Dr. Dhruv Galgotia, CEO, Galgotias University, Greater Noida, India
Preface
1. Gene Editing Governance and Genetic Engineering: A Framework for Regulating CRISPR Technology
Christian Kaunert and Richa Raghav
2. Application and Challenges of the CRISPR/Cas9 System for Gene Editing
Thanaporn Sriyakul, Saquib Ahmed, Bhupinder Singh, and Anjali Raghav
3. Impact of Genomics on Drug Discovery and Clinical Medicine in Public Healthcare: Fostering Disease Prevention and Enhancing Human Well-Being
Ashima Jain and Bhupinder Singh
4. Challenges and Approaches to Human Genome Editing
Saquib Ahmed and Bhupinder Singh
5. Precision Medicine Through Gene Editing: Pharmacogenomics and the Future of Disease Management in Clinical Healthcare
Kozma Dorottya Edina, Manmeet Kaur Arora, Bhupinder Singh, and Sahil Lal
6. Patenting the Genome: A Global Perspective of Intellectual Property Rights and Genetic Innovation
Soufiane Ouariach, Sahil Lal, Bhupinder Singh, and Manmeet Kaur Arora
7. Biosafety Issues Relating to Genome Editing in Plants and Its Impact on Human Health
Bhupinder Singh and Christian Kaunert
8. Gene Editing and Human Rights: Legal Implications of CRISPR Technology
Fatima Zahra Ouariach and Manmeet Kaur Arora
9. Genomic Innovations in Drug Discovery and Clinical Medicine
Shayut Pavapanunkul and Anjali Raghav
10. Impact of Genomics on Drug Discovery and Clinical Medicine: Fostering Gene Editing and Personalized Medicine, Bioinformatics and Artificial Intelligence
Rishabha Malviya and Bhupinder Singh
Biography
Bhupinder Singh, PhD, is Professor at Sharda University, India, and Honorary Professor at the
University of South Wales, UK. He has over 16 years of experience and has authored numerous
publications and conference presentations across law and emerging technologies.
Rishabha Malviya, PhD, is Associate Professor at Galgotias University, India, with expertise in
pharmaceutics and drug delivery. He has published over 200 papers, holds multiple patents, and
is listed among the world’s Top 2% Scientists per Stanford University.
Sahil Lal, PhD, is Assistant Professor of Law at Galgotias University, India. His work focuses on
intellectual property and emerging technologies, particularly artificial intelligence and innovation
policy.
Sathvik Belagodu Sridhar, PhD, is Associate Dean and Professor at RAK Medical and Health
Sciences University, UAE, with over 25 years of experience in clinical pharmacy and
pharmacovigilance research.
“A thorough, multidisciplinary examination of how genetic editing is revolutionizing medicine and providing fresh hope in the battle against complicated illnesses. . . . An extensive range of chapters on the ethical, legal, and societal consequences of gene editing, with a focus on human rights concerns and the legal frameworks that must adapt to incorporate the impact of gene editing. . . . An essential resource for healthcare experts, researchers, clinicians, and biomedical scientists in the future of healthcare and genetic technology.”
—From the Foreword by Dr. Dhruv Galgotia, CEO, Galgotias University, Greater Noida, India






